PET imaging with [18F]3′-deoxy-3′-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer

被引:0
|
作者
Hinrich A. Wieder
Hans Geinitz
Robert Rosenberg
Florian Lordick
Karen Becker
Alexander Stahl
Ernst Rummeny
Jörg R. Siewert
Markus Schwaiger
Jens Stollfuss
机构
[1] Technische Universität München,Department of Nuclear Medicine
[2] Technische Universität München,Department of Radiology
[3] Technische Universität München,Department of Radiotherapy
[4] Technische Universität München,Department of Surgery
[5] Technische Universität München,Department of Medicine III
[6] Technische Universität München,Department of Pathology
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2007年 / 34卷
关键词
Rectal cancer; Therapy monitoring; FLT-PET; Proliferation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:878 / 883
页数:5
相关论文
共 50 条
  • [21] Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine (18F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study
    Kairemo, Kalevi
    Santos, Elmer B.
    Macapinlac, Homer A.
    Patel, Shreyaskumar
    Conley, Anthony P.
    Hong, David S.
    Subbiah, Vivek
    DIAGNOSTICS, 2020, 10 (03)
  • [22] The use of 3′-deoxy-3′-18F-fluorothymidine (FLT) PET in the assessment of long-term survival in breast cancer patients treated with neoadjuvant chemotherapy
    Benjamin E. Ueberroth
    Jawana M. Lawhorn-Crews
    Lance K. Heilbrun
    Daryn W. Smith
    Janice Akoury
    Rouba Ali-Fehmi
    Nicole T. Eiseler
    Anthony F. Shields
    Annals of Nuclear Medicine, 2019, 33 : 383 - 393
  • [23] Reproducibility of 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET Tumor Volume Measurements
    Hatt, Mathieu
    Rest, Catherine Cheze-Le
    Aboagye, Eric O.
    Kenny, Laura M.
    Rosso, Lula
    Turkheimer, Federico E.
    Albarghach, Nidal M.
    Metges, Jean-Philippe
    Pradier, Olivier
    Visvikis, Dimitris
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (09) : 1368 - 1376
  • [24] Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours
    K. Herrmann
    M. Erkan
    M. Dobritz
    T. Schuster
    J. T. Siveke
    A. J. Beer
    H. J. Wester
    R. M. Schmid
    H. Friess
    M. Schwaiger
    J. Kleeff
    A. K. Buck
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 846 - 851
  • [25] Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours
    Herrmann, K.
    Erkan, M.
    Dobritz, M.
    Schuster, T.
    Siveke, J. T.
    Beer, A. J.
    Wester, H. J.
    Schmid, R. M.
    Friess, H.
    Schwaiger, M.
    Kleeff, J.
    Buck, A. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (05) : 846 - 851
  • [26] Exploratory Analysis of 18F-3'-deoxy-3'-fluorothymidine (18F-FLT) PET/CT-Based Radiomics for the Early Evaluation of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
    Fantini, Lorenzo
    Belli, Maria Luisa
    Azzali, Irene
    Loi, Emiliano
    Bettinelli, Andrea
    Feliciani, Giacomo
    Mezzenga, Emilio
    Fedeli, Anna
    Asioli, Silvia
    Paganelli, Giovanni
    Sarnelli, Anna
    Matteucci, Federica
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] Clinical value of 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography for diagnosis, staging and assessing therapy response in lung cancer
    Alwadani, Bandar
    Dall'Angelo, Sergio
    Fleming, Ian N.
    INSIGHTS INTO IMAGING, 2021, 12 (01)
  • [28] Altered Tissue 3′-Deoxy-3′-[18F]Fluorothymidine Pharmacokinetics in Human Breast Cancer following Capecitabine Treatment Detected by Positron Emission Tomography
    Kenny, Laura M.
    Contractor, Kaiyumars B.
    Stebbing, Justin
    Ai-Nahhas, Adil
    Palmieri, Carlo
    Shousha, Sami
    Coombes, R. Charles
    Aboagye, Eric O.
    CLINICAL CANCER RESEARCH, 2009, 15 (21) : 6649 - 6657
  • [29] Letter to the Editor re: Positron Emission Tomography with [18F]-3′-Deoxy-3′fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: a Pilot Study
    A. Chalkidou
    G. Mikhaeel
    M. J. O’Doherty
    P. K. Marsden
    Molecular Imaging and Biology, 2013, 15 : 521 - 522
  • [30] Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non-Small Cell Lung Cancer Using 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET
    Kahraman, Deniz
    Scheffler, Matthias
    Zander, Thomas
    Nogova, Lucia
    Lammertsma, Adriaan A.
    Boellaard, Ronald
    Neumaier, Bernd
    Ullrich, Roland T.
    Holstein, Arne
    Dietlein, Markus
    Wolf, Juergen
    Kobe, Carsten
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (12) : 1871 - 1877